These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36807750)

  • 21. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
    Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.
    Ohmoto A; Sato Y; Asaka R; Fukuda N; Wang X; Urasaki T; Hayashi N; Sato Y; Nakano K; Yunokawa M; Ono M; Tomomatsu J; Toshiyasu T; Mitani H; Takeuchi K; Mori S; Takahashi S
    Mod Pathol; 2021 Nov; 34(11):1979-1989. PubMed ID: 34247193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compound Genomic Alterations of TP53, PTEN, and RB1 Tumor Suppressors in Localized and Metastatic Prostate Cancer.
    Hamid AA; Gray KP; Shaw G; MacConaill LE; Evan C; Bernard B; Loda M; Corcoran NM; Van Allen EM; Choudhury AD; Sweeney CJ
    Eur Urol; 2019 Jul; 76(1):89-97. PubMed ID: 30553611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations.
    Kobayashi H; Kosaka T; Nakamura K; Shojo K; Hongo H; Mikami S; Nishihara H; Oya M
    BMC Med Genomics; 2021 Oct; 14(1):245. PubMed ID: 34627261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Bellone S; Jeong K; Halle MK; Krakstad C; McNamara B; Greenman M; Mutlu L; Demirkiran C; Hartwich TMP; Yang-Hartwich Y; Zipponi M; Buza N; Hui P; Raspagliesi F; Lopez S; Paolini B; Milione M; Perrone E; Scambia G; Altwerger G; Ravaggi A; Bignotti E; Huang GS; Andikyan V; Clark M; Ratner E; Azodi M; Schwartz PE; Quick CM; Angioli R; Terranova C; Zaidi S; Nandi S; Alexandrov LB; Siegel ER; Choi J; Schlessinger J; Santin AD
    Proc Natl Acad Sci U S A; 2024 Apr; 121(17):e2321898121. PubMed ID: 38625939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PD-L1, RB1 and mismatch repair protein immunohistochemical expression in neuroendocrine carcinoma, small cell type, of the uterine cervix.
    Morgan S; Slodkowska E; Parra-Herran C; Mirkovic J
    Histopathology; 2019 Jun; 74(7):997-1004. PubMed ID: 30667073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muscle-invasive Urothelial Cancer: Association of Mutational Status with Metastatic Pattern and Survival.
    Alessandrino F; Williams K; Nassar AH; Gujrathi R; Silverman SG; Sonpavde G; Shinagare AB
    Radiology; 2020 Jun; 295(3):572-580. PubMed ID: 32228295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
    Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma.
    Muto Y; Ryo E; Namikawa K; Takahashi A; Ogata D; Fujimura T; Yatabe Y; Aiba S; Yamazaki N; Mori T
    Pathol Int; 2021 May; 71(5):337-347. PubMed ID: 33751708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
    Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
    Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updates and management algorithm for neuroendocrine tumors of the uterine cervix.
    Salvo G; Gonzalez Martin A; Gonzales NR; Frumovitz M
    Int J Gynecol Cancer; 2019 Jul; 29(6):986-995. PubMed ID: 31263021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
    Lee SM; Sung CO
    Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational analysis of PDGFRA oncogene in high-grade neuroendocrine carcinoma of the uterine cervix in twelve Taiwanese women.
    Chang KL; Chao WR; Lee YJ; Lin YH; Han CP
    Taiwan J Obstet Gynecol; 2024 Jan; 63(1):125-126. PubMed ID: 38216252
    [No Abstract]   [Full Text] [Related]  

  • 34. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.
    Boruta DM; Schorge JO; Duska LA; Crum CP; Castrillon DH; Sheets EE
    Gynecol Oncol; 2001 Apr; 81(1):82-7. PubMed ID: 11277655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological characteristics and survival outcomes of patients with large cell neuroendocrine carcinoma of the uterine cervix: A systematic review and meta-analysis.
    Prodromidou A; Phelps DL; Pergialiotis V; Cunnea P; Thomakos N; Rodolakis A; Fotopoulou C; Haidopoulos D
    Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():212-220. PubMed ID: 35093830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
    Zhang X; Lv Z; Lou H
    BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Analysis of Genetic Alterations, HPV-Status, and PD-L1 Expression in Neuroendocrine Carcinomas of the Cervix.
    Takayanagi D; Hirose S; Kuno I; Asami Y; Murakami N; Matsuda M; Shimada Y; Sunami K; Komatsu M; Hamamoto R; Kato MK; Matsumoto K; Kohno T; Kato T; Shiraishi K; Yoshida H
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphic variability in the exon 19 of the RB1 gene and its flanking intronic sequences in HPV16-associated precancerous lesions in the Greek population.
    Tsakogiannis D; Moschonas GD; Daskou M; Stylianidou Z; Kyriakopoulou Z; Kottaridi C; Dimitriou TG; Gartzonika C; Markoulatos P
    J Med Microbiol; 2018 Nov; 67(11):1638-1644. PubMed ID: 30303478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
    Brcic L; Kuchler C; Eidenhammer S; Pabst D; Quehenberger F; Gazdar AF; Popper H
    Diagn Pathol; 2019 May; 14(1):47. PubMed ID: 31109352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.